Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

131 ARTÍCULOS , VIENDO DEL 91 AL 105

Human herpesvirus 6 (HHV-6) infection and risk of Alzheimer's disease: a systematic review and meta-analysis

Bastan F, Saeedi-Moghaddam F, Rashidian M, Mirhosseini F, Mozhgani SH.

BMC Neurol. 2025 Nov 22;25(1):516. doi: 10.1186/s12883-025-04500-1.

Sildenafil and risk of Alzheimer disease: a systematic review and meta-analysis

Chua WY, Lim LKE, Wang JJD, Mai AS, Chan LL, Tan EK.

Aging (Albany NY). 2025 Mar 17;17(3):726-739. doi: 10.18632/aging.206222. Epub 2025 Mar 17.

Evaluating the Bidirectional Causal Effects of Alzheimer's Disease Across Multiple Conditions: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies

Zhu H, Ni H, Yang Q, Ni J, Ji J, Yang S, Peng F.

Int J Mol Sci. 2025 Apr 10;26(8):3589. doi: 10.3390/ijms26083589.

Metabolic syndrome and risk of incident all-cause dementia, Alzheimer's disease and vascular dementia: a systematic review and meta-analysis of longitudinal studies

Qureshi D, Allen NE, Kuźma E, Littlejohns TJ.

Alzheimers Res Ther. 2025 Aug 23;17(1):198. doi: 10.1186/s13195-025-01825-4.

Exposure to autoimmune disorders is associated with increased Alzheimer's disease risk in a multi-site electronic health record analysis

Ramey GD, Tang A, Phongpreecha T, Yang MM, Woldemariam SR, Oskotsky TT, Montine TJ, Allen I, Miller ZA, Aghaeepour N, Capra JA, Sirota M.

Cell Rep Med. 2025 Mar 18;6(3):101980. doi: 10.1016/j.xcrm.2025.101980. Epub 2025 Feb 24.

Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensus

Perneczky R, Darby D, Frisoni GB, Hyde R, Iwatsubo T, Mummery CJ, Park KH, van Beek J, van der Flier WM, Jessen F.

J Prev Alzheimers Dis. 2025 Apr;12(4):100096. doi: 10.1016/j.tjpad.2025.100096. Epub 2025 Feb 18.

The Bidirectional Relationship Between Epilepsy and Alzheimer's Disease

Stewart D, Johnson EL.

Curr Neurol Neurosci Rep. 2025 Feb 8;25(1):18. doi: 10.1007/s11910-025-01404-y.

Early Alzheimer's disease (mild cognitive impairment or mild dementia): Prevalence, diagnostics, treatment options, and guidelines in Asia, Australasia, and Pacific nations countries

Hsu JL, Park KH, Panegyres PK, Huang YH, Eom YI, Prusty V, Tan LS, Shea YF.

J Prev Alzheimers Dis. 2025 Nov;12(9):100362. doi: 10.1016/j.tjpad.2025.100362. Epub 2025 Aug 30.

Brain Signatures of Very Early Cognitive Decline in Asymptomatic Middle-Aged Offspring of People With Alzheimer's Disease

Ramsingh N, Lin HM, Ouyang Y, Ravona-Springer R, Livny A, Soleimani L, Bendlin BB, Matatov A, Niv T, Shamir T, Ganmore I, Heymann A, Sano M, Azuri J, Beeri MS.

Int J Geriatr Psychiatry. 2025 Mar;40(3):e70060. doi: 10.1002/gps.70060.

Cross-Sectional Comparison of Structural MRI Markers of Impairment in a Diverse Cohort of Older Adults

Wisch JK, Petersen K, Millar PR, Abdelmoity O, Babulal GM, Meeker KL, Braskie MN, Yaffe K, Toga AW, O'Bryant S, Ances BM; HABS‐HD Study Team.

Hum Brain Mapp. 2025 Feb 1;46(2):e70133. doi: 10.1002/hbm.70133.

Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks

Kitagawa K, Yoshizawa H, Toi S, Todo K.

J Alzheimers Dis. 2025 Oct;107(3):1267-1274. doi: 10.1177/13872877251365629. Epub 2025 Aug 6.

Association between education and rate of cognitive decline among individuals with Alzheimer's disease: A multi-national European observational study

Popp ZT, Ang TFA, Hwang PH, Au R, Chen J.

J Alzheimers Dis. 2025 Aug;106(4):1463-1474. doi: 10.1177/13872877251352216. Epub 2025 Jun 26.

Disruptive resting state networks characterizing depressive comorbidity in Alzheimer's disease and mild cognitive impairment

von Gal A, Papa D, D'Auria M, Piccardi L.

J Alzheimers Dis. 2025 Jul;106(1):18-37. doi: 10.1177/13872877251337770. Epub 2025 May 6.

Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-β Immunotherapy: An Updated Meta-Analysis

Jeong SY, Suh CH, Lim JS, Shim WH, Heo H, Choi Y, Kim HS, Kim SJ, Lee JH.

Neurology. 2025 Apr 22;104(8):e213483. doi: 10.1212/WNL.0000000000213483. Epub 2025 Mar 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias